Indolent B-cell Lymphoma
Also known as: Indolent B-cell Lymphomas / Indolent B Cell Lymphoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01262 | Decitabine | 0 | Completed | 1 |
| DB12484 | Tetrahydrouridine | 0 | Completed | 1 |
| DB15721 | Natural Killer Cell | 1 | Completed | 1 |
| DB02701 | Nicotinamide | 1 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 | Completed | 1 |
| DB09027 | Ledipasvir | 2 | Completed | 1 |
| DB00073 | Rituximab | 2 | Completed | 1 |
| DB08934 | Sofosbuvir | 2 | Completed | 1 |
| DB11613 | Velpatasvir | 2 | Completed | 1 |
| DB09053 | Ibrutinib | 3 | Unknown Status | 1 |
| DB17235 | Linperlisib | 4 | Not Yet Recruiting | 1 |